EUVIMEDEUVIMED entdecken
EditorialOpen Access

MRGPRX2 in drug allergy: What we know and what we do not know

Pavel Kolkhir, Hydar Ali, Magda Babina, Didier Ebo, Vito Sabato, Jessy Elst, Stefan Frischbutter, Polina Pyatilova, Marcus Maurer

Journal of Allergy and Clinical Immunology · 2023-02 · 151 (2) · 410-412

DOI: 10.1016/j.jaci.2022.09.004 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023-02. Verfasst von Pavel Kolkhir und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, Berlin, Germany; Institute of Allergology, Charité-Univ…. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Anaphylaxis. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug HypersensitivityAnaphylaxisHumansReceptors, G-Protein-CoupledMast CellsReceptors, NeuropeptideCell DegranulationNerve Tissue Proteins

Stichwörter der Autor:innen

MRGPRX2NMBAanaphylaxisantibioticsdrug allergydrug hypersensitivitymast cellsvancomycin

Substanzen

Receptors, G-Protein-CoupledReceptors, NeuropeptideMRGPRX2 protein, humanNerve Tissue Proteins

Autor:innen und Institutionen

  • Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, Berlin, Germany; Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin a…
  • Department of Basic and Translational Sciences, University of Pennsylvania, School of Dental Medicine, Philadelphia, Pa.
  • Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Kolkhir, P., Ali, H., Babina, M., Ebo, D., Sabato, V., Elst, J., Frischbutter, S., Pyatilova, P., & Maurer, M. (2023). MRGPRX2 in drug allergy: What we know and what we do not know. Journal of Allergy and Clinical Immunology, 151(2), 410-412. https://doi.org/10.1016/j.jaci.2022.09.004

Vancouver

Kolkhir P, Ali H, Babina M, Ebo D, Sabato V, Elst J, et al. MRGPRX2 in drug allergy: What we know and what we do not know. Journal of Allergy and Clinical Immunology. 2023;151(2):410-412. doi:10.1016/j.jaci.2022.09.004

BibTeX
@article{Kolkhir2023,
  author = {Kolkhir, Pavel and Ali, Hydar and Babina, Magda and Ebo, Didier and Sabato, Vito and Elst, Jessy and Frischbutter, Stefan and Pyatilova, Polina and Maurer, Marcus},
  title = {MRGPRX2 in drug allergy: What we know and what we do not know},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2023},
  volume = {151},
  number = {2},
  pages = {410--412},
  doi = {10.1016/j.jaci.2022.09.004}
}
Kostenlos starten →